Rabbit Polyclonal HIG2 antibody. Suitable for ICC/IF and reacts with Human samples. Immunogen corresponding to Recombinant Fragment Protein within Human HILPDA aa 1 to C-terminus.
View Alternative Names
C7orf68, HIG2, HILPDA, Hypoxia-inducible lipid droplet-associated protein, Hypoxia-inducible gene 2 protein
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-HIG2 antibody (AB252976)
PFA-fixed, Triton X-100 permeabilized A549 (Human lung carcinoma cell line) cells stained for HIG2 (green) using ab252976 at 4 μg/ml in ICC/IF.
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
HIG2 is known to interact with other proteins involved in lipid metabolism. It does not function as part of a complex but influences the storage and mobilization of fats within cells. HIG2 expression can increase in response to hypoxic conditions which often occur in the tumor microenvironment. This association with hypoxia suggests its involvement not only in metabolism but also in cancer biology.
Pathways
HIG2 integrates into lipid metabolism and hypoxia response pathways. It interacts with proteins such as perilipin-1 on lipid droplets and others within the fatty acid metabolism pathway. Through these interactions HIG2 contributes to the homeostasis of lipids affecting how cells store and utilize energy under varying oxygen levels. The protein's modulation of lipid storage aligns it with mechanisms that cells use to adapt to hypoxic conditions which often occur in tumors or adipose tissues.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com